Bladder Instillation Therapy With Hyaluronic Acid and Chondroitin Sulfate Improves Symptoms of Postradiation Cystitis: Prospective Pilot Study

被引:17
作者
Gacci, Mauro [1 ]
Saleh, Omar [1 ]
Giannessi, Claudia [1 ]
Chini, Tommaso [1 ]
Della Camera, Pier Andrea [1 ]
Detti, Beatrice [2 ]
Livi, Lorenzo [2 ]
Agro, Enrico Finazzi [3 ]
Marzi, Vincenzo Li [1 ]
Minervini, Andrea [1 ]
Carini, Marco [1 ]
Oelke, Matthias [4 ]
Gravas, Stavros [5 ]
Semi, Sergio [1 ]
机构
[1] Univ Florence, Careggi Hosp, Dept Urol, Florence, Italy
[2] Univ Florence, Careggi Hosp, Dept Radiat Therapy, Florence, Italy
[3] Tor Vergata Univ, Dept Urol, Rome, Italy
[4] Hannover Med Sch, Dept Urol, Hannover, Germany
[5] Univ Hosp Larissa, Dept Urol, Larisa, Greece
关键词
Adjuvant radiotherapy; Bladder Drug Administration; Lower urinary tract symptoms; Prostate cancer; Sodium hyaluronate; PROSTATE-CANCER; RADICAL PROSTATECTOMY; RADIOTHERAPY; MANAGEMENT; DIAGNOSIS; TOXICITY; NOCTURIA; TRIAL;
D O I
10.1016/j.clgc.2016.01.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study, we evaluate the efficacy of hyaluronic acid and chondroitin sulfate instillation in men with symptomatic cystitis after radiation therapy for PCa. Of a total of 80 patients treated with RT for PCa, 30 of these reported LUTS and received instillation therapy for 1 year. HA-CS significantly reduced overall LUTS and bother as measured by the ICSI/ICPI questionnaire. Background: After radiotherapy (RD for prostate cancer (PCa), several patients reported lower urinary tract symptoms (LUTS) due to damage and discontinuation of the glycosaminoglycan layer of the bladder. Instillation of hyaluronic acid and chondroitin sulfate (HA-CS) represents replenishment therapy of the glycosaminoglycan layer. The aim of the study is to evaluate the efficacy and safety of HA-CS in men with symptomatic cystitis after RT for PCa. Materials and Methods: Eighty consecutive men were treated with RT for PCa; 30 of these (37.5%) reported clinically relevant LUTS and associated bother as measured by the Interstitial Cystitis Symptom Index and Problem Index (ICSI/ICPI) Questionnaire 3 months after RT. Symptomatic patients received instillation therapy with HA-CS weekly for the first month and then at weeks 6, 8, and 12. All patients completed the ICSI/ICPI questionnaire before and after RT and at the end of HA-CS treatment. Results: HA-CS significantly reduced postradiation LUTS (P < .001) and bother (P = .006). Age, Gleason score, and radiation dose were the main determinants of worsening of LUTS after radiation (ICSI score baseline vs. postradiation: P = .047, .043, and .023). In multivariate analysis, only age influenced LUTS worsening after RT (P = .01). Age, radiation dose, and radiation toxicity were related to recovery of LUTS (ICSI score postradiation vs. post HA-CS P = .041, P = .050, and P = .046). In multivariate analysis, no factor was statistically significant. Conclusions: A remarkable worsening of symptoms and bother was observed after RT. HA-CS instillation is a safe treatment and resulted in an improvement of LUTS irrespective of age and clinical features, with full recovery of urinary bother. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:444 / 449
页数:6
相关论文
共 22 条
[1]  
Bassi Pier Francesco, 2013, EUR MED J UROL, V1, P33
[2]   Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911) [J].
Bolla, Michel ;
van Poppel, Hein ;
Tombal, Bertrand ;
Vekemans, Kris ;
Da Pozzo, Luigi ;
de Reijke, Theo M. ;
Verbaeys, Antony ;
Bosset, Jean-Francois ;
van Velthoven, Roland ;
Colombel, Marc ;
van de Beek, Cees ;
Verhagen, Paul ;
van den Bergh, Alphonsus ;
Sternberg, Cora ;
Gasser, Thomas ;
van Tienhoven, Geertjan ;
Scalliet, Pierre ;
Haustermans, Karin ;
Collette, Laurence .
LANCET, 2012, 380 (9858) :2018-2027
[3]   Diagnosis and Treatment of Interstitial Cystitis/Painful Bladder Syndrome: A Review [J].
Butrick, Charles W. ;
Howard, Fred M. ;
Sand, Peter K. .
JOURNAL OF WOMENS HEALTH, 2010, 19 (06) :1185-1193
[4]   Intravesical hyaluronic acid and chondroitin sulphate for bladder pain syndrome/interstitial cystitis: long-term treatment results [J].
Cervigni, M. ;
Natale, F. ;
Nasta, L. ;
Mako, A. .
INTERNATIONAL UROGYNECOLOGY JOURNAL, 2012, 23 (09) :1187-1192
[5]  
D'Amico AV, 2012, CANCER, V95, P281
[6]   Acute Radiation-Induced Nocturia in Prostate Cancer Patients Is Associated With Pretreatment Symptoms, Radical Prostatectomy, and Genetic Markers in the TGFβ1 Gene [J].
De Langhe, Sofie ;
De Ruyck, Kim ;
Ost, Piet ;
Fonteyne, Valerie ;
Werbrouck, Joke ;
De Meerleer, Gert ;
De Neve, Wilfried ;
Thierens, Hubert .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (02) :393-399
[7]   Intensity-modulated radiotherapy as primary treatment for prostate cancer: Acute toxicity in 114 patients [J].
De Meerleer, G ;
Vakaet, L ;
Meersschout, S ;
Villeirs, G ;
Verbaeys, A ;
Oosterlinck, W ;
De Neve, W .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (03) :777-787
[8]   Quality of Life and Sexual Health in the Aging of PCa Survivors [J].
Gacci, Mauro ;
Baldi, Elisabetta ;
Tamburrino, Lara ;
Detti, Beatrice ;
Livi, Lorenzo ;
De Nunzio, Cosimo ;
Tubaro, Andrea ;
Gravas, Stavros ;
Carini, Marco ;
Serni, Sergio .
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2014, 2014
[9]   Patient-Reported Outcomes in Bladder Pain Syndrome: Qui Auget Dolorem, Auget et Scientiam (As Pain Increases, So Increases Knowledge) [J].
Giannantoni, Antonella .
EUROPEAN UROLOGY, 2012, 61 (02) :280-281
[10]   Combined intravesical sodium hyaluronate/chondroitin sulfate therapy for interstitial cystitis/bladder pain syndrome: a prospective study [J].
Giberti, Claudio ;
Gallo, Fabrizio ;
Cortese, Pierluigi ;
Schenone, Maurizio .
THERAPEUTIC ADVANCES IN UROLOGY, 2013, 5 (04) :175-179